News

• 2021.09.02 news
  Our efforts for the medical application of artificial intelligence (AI) (hemodialysis, respiratory diagnosis, etc.) were featured in Nikkei Biotechnology and Business
• 2021.08.18 news
  Notice Regarding Approval of Listing on the Tokyo Stock Exchange Mothers Market
• 2021.07.19 news
  Nikkei Sangyo Shimbun featured our work on AI project
• 2021.07.06 news
  Development of a swallowing function evaluation system using artificial intelligence was featured in the Chemical Daily.
• 2021.06.25 news
  Collaboration agreement with Nipro Corporation on chronic dialysis system support was featured in the morning edition of Nihon Keizai Shimbun
• 2021.06.25 news
  Collaboration Agreement with Nipro Corporation for the Development of Chronic Dialysis Support System.
• 2021.01.17 news
  Option agreement with Daiichi Sankyo Co., Ltd. for the treatment of respiratory diseases including COVID-19 pneumonia and other lung injuries
• 2020.12.10 news
  Our research on a drug (RS5614) for the treatment of lung injury associated with new coronavirus infections was published in the Bunshun Mook “Super Doctors Teach Us the Latest Treatment 2021”.
• 2020.12.04 news
  Investigator-initiated clinical trial on RS5614, for the treatment of lung injuries associated with COVIC-19 infections at Northwestern Memorial hospital, was reported by WGN-TV, Chicago news.
• 2020.11.27 news
  Investigator-initiated clinical trial to be started at Northwestern University as one of our U.S. initiatives for the treatment (RS5614) of lung injuries associated with COVID-19 infections (ClinicalTrials.gov: NCT04634799).